Services



 

We are your service provider for customised development of ELISA and EIA- predominantly for clients of pharmaceutical and in-vitro-diagnostics industry.

Our team has many years of experience in development, optimisation and validation of immunoassays for pharma and ivd.
By request the development is carried out in compliance with the guideline Q2(R1) (Q2A
and Q2B) or "Guidance for Industry 2001: Bioanalytical Method Validation" (FDA) and following documents as well as the European Directive 98/79/EG according in-vitro-diagnostics.

For assay development we are certified in compliance with DIN EN ISO 9001:2008.
 
 
 
Do you have questions about immunoassays?

Please feel free to contact us.

Your contact person:

Dr. Peter Rauch
Tel.: + 49 (0) 7522 /79527-12
info@candor-bioscience.de
 
 
 
© CANDOR Bioscience GmbH